KR100974584B1 - Health assistance food included the euphorbia humifusa wild and the manufacturing method therof - Google Patents
Health assistance food included the euphorbia humifusa wild and the manufacturing method therof Download PDFInfo
- Publication number
- KR100974584B1 KR100974584B1 KR1020100041200A KR20100041200A KR100974584B1 KR 100974584 B1 KR100974584 B1 KR 100974584B1 KR 1020100041200 A KR1020100041200 A KR 1020100041200A KR 20100041200 A KR20100041200 A KR 20100041200A KR 100974584 B1 KR100974584 B1 KR 100974584B1
- Authority
- KR
- South Korea
- Prior art keywords
- manufacturing
- wild
- ginseng
- health
- euphorbia humifusa
- Prior art date
Links
- 241001555026 Euphorbia humifusa Species 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 235000013305 food Nutrition 0.000 title abstract description 22
- 230000036541 health Effects 0.000 title abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 6
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 5
- 235000015872 dietary supplement Nutrition 0.000 claims description 38
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 15
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 14
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 13
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 13
- 229940010454 licorice Drugs 0.000 claims description 13
- 206010004194 Bed bug infestation Diseases 0.000 claims description 11
- 240000002045 Guettarda speciosa Species 0.000 claims description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 10
- 239000004615 ingredient Substances 0.000 claims description 5
- 241001414835 Cimicidae Species 0.000 claims description 4
- 241000283074 Equus asinus Species 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 3
- 241000202807 Glycyrrhiza Species 0.000 claims 3
- 235000003276 Apios tuberosa Nutrition 0.000 claims 1
- 244000170226 Voandzeia subterranea Species 0.000 claims 1
- 235000013030 Voandzeia subterranea Nutrition 0.000 claims 1
- 235000007924 ground bean Nutrition 0.000 claims 1
- 231100000419 toxicity Toxicity 0.000 abstract description 6
- 230000001988 toxicity Effects 0.000 abstract description 6
- 241000001727 Tropicoporus linteus Species 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 241000411851 herbal medicine Species 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 241001247821 Ziziphus Species 0.000 description 9
- 241001327638 Cimex lectularius Species 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 208000007882 Gastritis Diseases 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 5
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 5
- 208000000689 peptic esophagitis Diseases 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 208000002720 Malnutrition Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000001071 malnutrition Effects 0.000 description 4
- 235000000824 malnutrition Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 208000015380 nutritional deficiency disease Diseases 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 206010019133 Hangover Diseases 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002489 hematologic effect Effects 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 235000017443 Hedysarum boreale Nutrition 0.000 description 2
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 2
- 241000361919 Metaphire sieboldi Species 0.000 description 2
- 241000219492 Quercus Species 0.000 description 2
- 235000016976 Quercus macrolepis Nutrition 0.000 description 2
- 230000016571 aggressive behavior Effects 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010009887 colitis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 2
- 231100000062 no-observed-adverse-effect level Toxicity 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 208000026872 Addison Disease Diseases 0.000 description 1
- 206010001488 Aggression Diseases 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- SKPPEIDJGJGRGK-UHFFFAOYSA-N Panacen Natural products CCC1=CC=CC2=C1C1OC(C=C=CBr)CC1O2 SKPPEIDJGJGRGK-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 241000789545 Trimeria grandifolia Species 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000012761 aggressive behavior Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000025302 chronic primary adrenal insufficiency Diseases 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000020650 eye health related herbal supplements Nutrition 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000019997 soju Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 땅빈대를 포함한 건강보조식품 및 그 제조방법에 관한 것으로써, 특히, 인체에 유용한 땅빈대를 주원료로 하여 인체에 무해하면서 유익한 건강보조식품 및 그 제조방법에 관한 것이다.The present invention relates to a dietary supplement comprising a bedbug, and to a method of manufacturing the same, and more particularly, to a dietary supplement that is harmless to a human body and is beneficial to the human body using a bedbug useful as a main ingredient.
핵가족화, 개인주의화, 야간활동의 인구증가, 대중소비시대, 소비패턴의 다양화, 편리성 추구, 그리고 여성의 사회진출 증가 등의 사회경제적인 환경의 변화로 식생활 구조의 변화를 겪고 있다.The dietary structure is undergoing a change in the socioeconomic environment, such as nuclear familyization, individualization, population growth at night, the age of mass consumption, diversification of consumption patterns, the pursuit of convenience, and the increase of women's social entry.
이러한 식사 구성에 대한 의식변화와 간편식에 대한 소비자의 요구 증가는 편의성을 추구하는 경향으로 나타나기 시작하였다. This change of consciousness about the composition of meals and the increasing demand of consumers for simple foods began to appear as a tendency to seek convenience.
그러나 이러한 현대인의 잘못된 식생활은 영양부족, 영양 과잉 및 잘못된 영양정보에 의한 영양불량을 초래하기 쉽다.However, such modern eating habits are likely to lead to malnutrition due to malnutrition, overnutrition and incorrect nutrition information.
영양부족으로 인한 영양불량은 빈혈 등 여러 질병을 일으키게 되고 영양소의 과잉섭취는 체중 과다 및 비만을 유발하여 오늘날 보건문제로 대두하고 있을 뿐 아니라 동맥경화증, 당뇨병, 고혈압과 같은 만성 퇴행성 질환의 발병을 더욱 가중시키게 된다.Malnutrition due to malnutrition causes various diseases such as anemia, and excessive intake of nutrients causes overweight and obesity, which are emerging as a health problem today, and further develop chronic degenerative diseases such as arteriosclerosis, diabetes, and high blood pressure. Weighted.
또한, 각종 암, 악성종양, 심장병, 신장병 등의 발병과 수명단축 등의 심각한 상태에 이르고 있다.In addition, serious conditions, such as the development of various cancers, malignant tumors, heart disease, kidney disease, etc. and shortened lifespan have been reached.
이에 각종 질병을 예방하고 치료에 도움을 주기 위한 기능성 보조식품이 다수 소개되고 있다.Many functional supplements have been introduced to help prevent and treat various diseases.
최근에는 상기와 같이 질병예방 뿐만 아니라 웰빙(Wellbeing)바람과 함께 건강에 대한 관심이 더 높아지면서 사람의 체질을 바꾸고 부작용이 없는, 생약재를 이용한 건강보조식품들이 많이 판매되고 있다.Recently, as well as the prevention of disease as well as the health (Wellbeing) wind and attention to health is increasing more and more people are changing the constitution and no side effects, using the herbal supplements are sold a lot of health supplements.
하지만 대부분이 생약재들은 생약재 특유의 쓴맛, 신맛으로 인하여 생약의 좋은 점을 알고도 복용을 피하게 된다. However, most of the herbal medicines because of the unique bitterness and sour taste of the herbal medicine, even if you know the goodness of the herbal medicine to avoid taking.
또한, 생약재 자체가 가지고 있는 독성과 성질로 인하여 생약재를 혼합할 시 이들의 혼합에 주의를 기울여야하고, 또한 독성을 중화시킬 별도의 전처리를 하여야 하며, 그렇지 않을 경우에는 부작용이 발생하기도 한다.In addition, due to the toxicity and properties of the herbal medicine itself, care should be taken when mixing the herbal medicines, and additional pretreatment to neutralize the toxicity, otherwise side effects may occur.
또한, 생약재 중 인체에 유익한 땅빈대를 이용한 건강보조식품은 아직까지 개발되어 있지 않은 상태이다.In addition, the health supplement foods using ground bedbugs beneficial to the human body of herbal medicines has not been developed yet.
본 발명에서는 상기의 문제점들을 해결하기 위한 것으로, 독성이 없으면서 인체에 유용한 땅빈대를 주원료로 하여 인체에 무해하면서 유익한 건강보조식품을 제공하려는 목적이 있다.In the present invention, to solve the above problems, there is an object to provide a health supplement food that is harmless to the human body as a main raw material is not toxic and useful to the human body.
본 발명의 땅빈대를 포함한 건강보조식품의 제조방법은, 땅빈대(Euphorbia Humifusa wild), 인삼, 당귀, 상황버섯, 감초, 대추를 각각 정선하여 재료를 준비하는 단계 및 상기 정선한 재료들을 용기에 넣고, 여기에 물을 넣고 100 ~ 120 ℃에서 1 ~ 4시간 동안 추출하는 단계를 포함하여 구성된다.In the manufacturing method of the health supplement foods, including the earthworm bed of the present invention, the step of preparing the material by selecting each of the earthworm ( Euphorbia Humifusa wild ), ginseng, Angelica, situation mushrooms, licorice, jujube and the selected ingredients in a container It is put, and water is put here and is configured to include the step of extracting for 1 to 4 hours at 100 ~ 120 ℃.
또한, 상기 추출하는 단계시, 땅빈대, 인삼, 당귀, 상황버섯, 감초, 대추를 1 : 0.02 ~ 0.1 : 0.02 ~ 0.1 : 0.01 ~ 0.05 : 0.02 ~ 0.1 : 0.05 ~ 0.2 중량비로 넣고 추출하는 것이 좋다.In addition, during the extracting step, it is good to put the ground bug, ginseng, Angelica, situation mushroom, licorice, jujube 1: 1: 0.02 ~ 0.1: 0.02 ~ 0.1: 0.01 ~ 0.05: 0.02 ~ 0.1: 0.05 ~ 0.2 by weight .
본 발명에 의해, 인체에 유용한 땅빈대를 주원료로 하여 인체에 무해하면서 유익한 건강보조식품이 제공된다.According to the present invention, a beneficial health supplement food is provided that is harmless to the human body with the main raw material useful for the human body.
도 1은 본 발명의 땅빈대를 포함한 건강보조식품의 제조방법도.1 is a manufacturing method of the dietary supplement containing the ground bag of the present invention.
본 발명의 땅빈대를 포함한 건강보조식품의 제조방법에 대하여 설명하면 다음과 같다.Referring to the manufacturing method of the health supplement food including the ground bug of the present invention.
1) 재료 준비단계1) Material Preparation Step
땅빈대, 인삼, 당귀, 상황버섯, 감초, 대추를 정선하여 준비한다.Prepare by selecting land bedbug, ginseng, donkey, situation mushroom, licorice and jujube.
땅빈대(Euphor bia humifusa)는 대극과에 딸린 한해살이풀로서, 풀밭이나 마당, 길옆에 흔히 자라는 식물이다. Euphor bia humifusa is an annual herb that accompanies the Great Family , and is a common plant growing in grass, yard, and road .
땅빈대는 플라보노이드와 사포닌이 주성분으로 잎에는 탄닌질이 10 % 이상 들어 있으며 몰식자산, 메틸에스테르, 마쿨라통, 시토스테롤, 알칼로이드 등이 함유되어 있고, 항암작용과 해독작용, 항균작용, 진정작용 등에 효능이 있다고 알려 져 있다.It is the main ingredient of flavonoids and saponins, and leaves contain more than 10% of tannins, and contain glutinous assets, methyl esters, maculaton, cytosterols, alkaloids, etc. It is known that.
또한, 한방에서는 땅빈대의 효능으로 이질, 설사, 위염, 대장염, 감기로 인한 기침, 혈변, 토혈, 자궁출혈, 혈뇨, 잇몸염증, 대상포진, 인후염 등에 효과가 있다고 한다.In addition, it is said that herbal medicine is effective for dysentery, diarrhea, gastritis, colitis, cold cough, bloody stool, hemorrhage, uterine bleeding, hematuria, gum inflammation, shingles, and sore throat.
인삼(Panax ginseng C.A.Mey., Ginseng)은 사포닌(saponin), 파나센 (panacene), 파나퀼론(panaquilon) 및 파낙신(panaxin) 등의 약용성분과 단백질, 핵산, 필수 지방산, 필수 아미노산을 비롯하여 각종 무기질, 비타민 및 당류, 콜린(choline) 등의 다양한 영양성분을 함유하고 있어 약용뿐만 아니라, 건강식품으로서도 귀중한 자원이다.Ginseng (Panax ginseng CAMey., Ginseng) is a medicinal ingredient such as saponin, panacene, panaquilon and panaxin, as well as proteins, nucleic acids, essential fatty acids and essential amino acids. Containing various nutrients such as minerals, vitamins and sugars, and choline, it is a valuable resource as well as medicinal foods.
인삼은 예로부터 인체의 신진대사를 촉진시키고 강장작용을 하는 보약으로 애용되어 왔으며 한방에 따르면 신경을 안정시켜 주고, 스트레스성 자극에 대한 저항성을 높여주며, 혈당을 강화시키고, 면역력을 강화시켜 주는 약리효과가 매우 우수하다.Ginseng has long been used as a medicine to promote metabolism and tonic action of the human body. According to Chinese medicine, ginseng stabilizes nerves, increases resistance to stress stimuli, strengthens blood sugar and strengthens immunity. The effect is very good.
당귀(當歸)는 미나리과의 다년생 여러해살이풀로써, 한방에서는 당귀뿌리를 약재로 사용하는데, 이는 온성정혈약, 아픔멎이약, 진정약, 강장약으로 빈혈증과 부인병에 주로 쓰인다.Danggui (當歸) is a perennial perennial plant of the family Apiaceae, in which oriental medicine is used as a medicinal root, which is used for anemia and gynecological diseases as a warming pill, pain pill, sedative, tonic.
상황버섯(Phellinus linteus)은 고산지대에 서식하고 있는 산뽕나무, 참나무, 밤나무, 상수리나무 등의 고목에서 자생하는 희귀한 담자균류의 다년생 버섯으로서, 흔히 "목질진흙버섯"이라고 한다. Phellinus linteus ( Phellinus linteus ) is a rare perennial mushroom that grows in the alpine tree, such as wild mulberry, oak, chestnut, and oak, and is often called "wood mud."
이러한 상황버섯은 칼륨, 칼슘, 마그네슘, 비타민 B2, B3, C, 섬유질 아미노산의 성분외에 다당류(polysaccharide)를 함유하고 있는데, 이 물질이 바로 면역활성 작용을 하는 것으로 알려져 왔다. These situation mushrooms contain polysaccharides in addition to the components of potassium, calcium, magnesium, vitamins B2, B3, C, and fibrous amino acids, which have been known to have an immunoactive effect.
감초(licorice root)는 쌍떡잎식물 장미목 콩과의 여러해살이풀로써, 한방에서는 감초뿌리를 약재로 쓰이는데, 이는 가래삭임작용, 완화작용, 항염증작용과 진경작용, 항히스타민작용 등이 있으며, 단맛이 있으므로 약품의 맛고침약으로도 쓰이며, 독풀이약이나 부형약, 위십이지장궤양, 애디슨병, 기관지천식, 황달과 간염, 습진을 비롯한 피부병 등에 널리 쓰이고 있다.Licorice (licorice root) is a perennial herb of the dicotyledonous plant Rosaceae, in oriental medicine, licorice root is used as a medicinal herb, which has sputum cutting effect, alleviation effect, anti-inflammatory effect, anti-inflammatory effect, antihistamine effect, and so on. It is also used as a taste and aggression medicine, and widely used in poisonous medicines, excipients, gastroduodenal ulcers, Addison's disease, bronchial asthma, jaundice and hepatitis, eczema and other skin diseases.
대추(date)는 대추나무(Zizyphus jujuba var. inermis)의 열매로서, 한방에서는 이뇨·강장(强壯)·완화제(緩和劑)로 쓰인다.
Date is the fruit of Zizyphus jujuba var. Inermis, and is used as a diuretic, tonic, and emollient in Chinese medicine.
2) 추출하는 단계2) extracting step
상기 정선한 재료들을 용기에 넣고 여기에 물을 넣고 100 ~ 120 ℃에서 1 ~ 4시간 동안 열수추출하여 건강보조식품을 제조한다.The selected ingredients are put in a container, water is added thereto, and hot water extraction is performed at 100 to 120 ° C. for 1 to 4 hours to prepare health supplement food.
또한, 상기 추출시, 땅빈대, 인삼, 당귀, 상황버섯, 감초, 대추를 1: 0.02 ~ 0.1 : 0.02 ~ 0.1 : 0.01 ~ 0.05 : 0.02 ~ 0.1 : 0.05 ~ 0.2 중량비로 넣고 추출하는 것이 좋다.
In addition, during the extraction, it is good to extract the ground bug, ginseng, Angelica, situation mushroom, licorice, jujube 1: 0.02 ~ 0.1: 0.02 ~ 0.1: 0.01 ~ 0.05: 0.02 ~ 0.1: 0.05 ~ 0.2 by weight.
즉, 본원 발명자는 수많은 한방재료를 이용하여 연구를 해온 결과, 그 중 항암작용과 해독작용, 항균작용, 진정작용을 나타내는 땅빈대를 주원료로 하여 인삼, 당귀, 상황버섯, 감초, 대추와 함께 열수추출할 시 인체에 무해하여 부작용이 없으면서 역류성 식도염, 위염, 대장염 및 숙치해소 등에 인체에 유익한 건강보조식품이 제조됨을 알 수 있었다.
In other words, the present inventors have studied using a number of herbal ingredients, the main raw material of the anti-cancer, detoxification, antibacterial action, soothing action, ginseng, Angelica, situation mushroom, licorice, jujube When extracted, it was found that the health supplements that are beneficial to the human body are prepared for reflux esophagitis, gastritis, colitis, and hangover without any side effects.
이하, 실시예와 실험예를 통하여 본 발명에 대해 상세하게 설명하나, 이들이 본 발명의 범위를 제한하는 것은 아니다.Hereinafter, the present invention will be described in detail with reference to Examples and Experimental Examples, but these do not limit the scope of the present invention.
<실시예 1> 본 발명의 땅빈대를 포함한 건강보조식품1 제조Example 1 Preparation of Health Supplement Food 1 Including the Bedbug of the Present Invention
땅빈대(Euphorbia Humifusa wild), 인삼, 당귀, 상황버섯, 감초, 대추를 각각 정선하여 준비하였다. Euphorbia Humifusa wild , ginseng, Angelica, situation mushroom, licorice and jujube were prepared by selection.
상기 정선된 땅빈대 20g, 인삼 0.5g, 당귀 0.5g, 상황버섯 0.3g, 감초 0.5g, 대추 1.5g을 용기에 넣은 후 여기에 물 1000cc를 넣고 110 ℃에서 3시간 동안 추출하여 건강보조식품1을 제조하였다.
The selected ground bedbug 20g, ginseng 0.5g, Angelica 0.5g, situation mushroom 0.3g, licorice 0.5g, jujube 1.5g into a container, 1000cc of water and extracted for 3 hours at 110 ℃ for health supplement food 1 Was prepared.
<실시예 2> 본 발명의 땅빈대를 포함한 건강보조식품2 제조Example 2 Preparation of Health Supplement Food 2 Including the Bedbug of the Present Invention
땅빈대(Euphorbia Humifusa wild), 인삼, 당귀, 상황버섯, 감초, 대추를 각각 정선하여 준비하였다. Euphorbia Humifusa wild , ginseng, Angelica, situation mushroom, licorice and jujube were prepared by selection.
상기 정선된 땅빈대 20g, 인삼 1.5g, 당귀 1.5g, 상황버섯 1.0g, 감초 1.5g, 대추 2.5g을 용기에 넣은 후 여기에 물 1000cc를 넣고 110 ℃에서 3시간 동안 추출하여 건강보조식품2를 제조하였다.
The selected land bedbug 20g, ginseng 1.5g, Angelica 1.5g, situation mushroom 1.0g, licorice 1.5g, jujube 2.5g into a container and put 1000cc of water and extracted for 3 hours at 110 ℃ health supplement food 2 Was prepared.
<비교예 1> 건강보조식품 제조Comparative Example 1 Preparation of Health Supplement
땅빈대(Euphorbia Humifusa wild)를 정선하여 준비하였다. Euphorbia Humifusa wild was prepared by selection.
상기 정선된 땅빈대 20g을 용기에 넣은 후 여기에 물 1000cc를 넣고 110 ℃에서 3시간 동안 추출하여 건강보조식품을 제조하였다.
20 g of the selected ground bedbugs were put in a container, and 1000 cc of water was added thereto, followed by extraction at 110 ° C. for 3 hours to prepare a health supplement.
<실험예 1> 땅빈대(Euphorbia Humifusa wild)의 독성측정Experimental Example 1 Toxicity Measurement of Euphorbia Humifusa wild
본 발명의 주재료인 땅빈대(Euphorbia Humifusa wild)의 독성을 확인하기 위해 한국화학시험연구원에서 랫드를 이용하여 실시예1의 땅빈대를 주원료로 한 건강보조식품1을 2주 동안 경구 투여시 나타나는 독성 반응 평가를 실시하였으며, 기본적으로 식품의약품안정청 고시 제2005-60호 "의약품 등 독성시험 기준"에 준하여 수행하였다.To confirm the toxicity of Euphorbia Humifusa wild , the main ingredient of the present invention, the toxicity appeared when oral administration of the dietary supplement 1, the main raw material of Example 1 for 2 weeks, using rats from the Korea Testing and Research Institute Response evaluation was carried out, and basically was performed in accordance with Korean Food and Drug Administration Notice No. 2005-60, "Toxicity Test Standard for Drugs, etc.".
이에 대한 실험방법 및 결과는 아래와 같다.Experimental method and results are as follows.
1. 실험방법1. Experimental method
SD계 랫드를 이용하여 시험군당 암, 수 각 5마리에 땅빈대를 2 주 동안 경구 투여하였다.SD rats were orally administered to the male and female rats for 5 weeks for 2 weeks.
시험물질(실시예1의 땅빈대를 주원료로 한 건강보조식품1)의 투여용량은 62.5, 125, 250 mg/kg/day로 설정하여 투여하였으며, 대조군에는 부형제만을 투여하였다.The dose of the test substance (Health supplement foods with the main raw material of Example 1) was set at 62.5, 125, 250 mg / kg / day, and only the excipient was administered to the control group.
시험물질 투여기간 동안 임상증상, 체중 증가량, 사료 소비량을 관찰하였으며, 투여 종료시에 모든 동물에 대하여 뇨 검사, 혈액학적 검사 및 혈액생화학적 검사를 실시하였다.Clinical symptoms, weight gain and feed consumption were observed during the administration of the test substance. At the end of the administration, urine, hematological and hematological tests were performed on all animals.
또한, 부검시 장기에 대하여 육안적으로 병리학적 검사를 실시하였다.
In addition, organs were visually examined for organs at necropsy.
2. 실험결과2. Experimental Results
상기 시험기간 동안 대조군 및 모든 시험군의 동물에서 투여 후 8일 째부터 입모, 민감함 반응 및 공격성 행동이 관찰되었으나 11일째 모두 회복하였고, 사망동물이 관찰되지 않았다.During the test period, in the control group and animals of all test groups, hair growth, sensitive response, and aggressive behavior were observed from day 8 after administration, but all recovered on day 11, and no dead animals were observed.
또한, 체중변화, 사료, 음수 섭취량 뇨검사, 혈액학적 검사에서 유의적인 변화는 관찰되지 않았으나 혈액생화학적 검사에서 수컷의 경우 대조군과 비교하여 ALP, BUN, IP 측정치에 유의적인 변화를 보였고, 암컷의 경우는 Cholesterol, IP, Na, Cl 측정치에 유의적인 변화를 보였다.In addition, no significant changes were observed in weight change, feed, negative intake urine test, and hematological test. However, blood biochemical test showed significant changes in ALP, BUN, and IP measurements in males compared to controls. The case showed a significant change in Cholesterol, IP, Na and Cl measurements.
그러나 이는 암컷과의 상관성이 없고, 또한 측정치가 정상범위 안에 포함되어 이는 시험물질 투여에 의한 변화라 판단되지 않는다.However, this does not correlate with females, and since the measurement is within the normal range, it is not considered to be a change by administration of the test substance.
부검소견에 있어서는 대조군 및 모든 시험군동물에서 소장에 용종이 관찰되었으나 이는 전례에서 관찰된 것으로 시험물질이 아닌 부형제의 영향이라 판단된다. In autopsy findings, polyps were observed in the small intestine in control and all test animals, but this was observed in all cases and it is considered that the effect of excipient is not test substance.
이상의 결과로 부터 땅빈대를 62.5, 125 및 250 mg/kg/day로 설정하여 2주동안 경구투여한 결과, 최고 투여용량인 250 mg/kg/day까지 유의할 만한 독성학적인 변화가 없었으므로 무해용량(NOAEL; No Observed Adverse Effect Level)은 250 mg/kg/day이상으로 판단된다.
From the above results, oral dosing for 2 weeks at 62.5, 125, and 250 mg / kg / day was found to have no significant toxicological change until the highest dose of 250 mg / kg / day. NOAEL; No Observed Adverse Effect Level) is determined to be greater than 250 mg / kg / day.
<실험예 2> 임상설문조사Experimental Example 2 Clinical Survey
상기 실시예 1에 제조된 건강보조식품에 대해서 평소에 위염, 역류성 식도염, 피로를 호소하는 20 대 ~ 50 대 성인 남녀를 각각 연령대별로 5 명씩 총 20 명을 대상으로 조사를 실시하였다.The dietary supplements prepared in Example 1 were examined in a total of 20 adults and 5 adults of 20s to 50s, who commonly complain of gastritis, reflux esophagitis, and fatigue.
비교대상으로 시중에 판매되고있는 건강보조제들(위염개선관련 건강보조식품, 역류성 식도염개선 관련 건강보조식품, 피로회복자양강장제)을 이용하였다.For comparison, we used commercially available health supplements (health supplements related to gastritis improvement, health supplements related to reflux esophagitis and fatigue recovery tonic).
이때, 1일 2회, 1회당 200 ml씩 30일간 섭취하도록 하였으며, 그 후 설문 조사를 하였다.At this time, twice daily, 200 ml each time to take 30 days, and then questionnaire.
효과의 정도를 5 점법에 따라 응답하도록 하였으며, 그 수치를 평균을 내어 하기 표 1에 나타내었다.(* 기호도 기준; 1. 효과가 전혀 없다., 3. 보통이다., 5. 효과가 아주 좋다.)The degree of the effect was responded according to the five-point method, and the average was shown in Table 1 below (average * symbol; 1. No effect at all, 3. Moderate., 5. The effect was very good. .)
상기 표 1에 나타나 있듯이, 비교대상들은 최소 3개월이상 섭취를 하여야 일부 개선효과들을 확인할 수 있는 반면, 본 발명의 실시예 1에 따른 건강보조식품이 단기간에 위염개선, 역류성 식도염 개선, 피로회복등에 효과를 나타냄을 알 수 있었다.
As shown in Table 1, the comparison subjects can confirm some improvement effects should be taken at least three months, while the health supplement according to Example 1 of the present invention in gastritis improvement, reflux esophagitis improvement, fatigue recovery, etc. It can be seen that the effect.
<실험예 3> 숙취해소정도 조사Experimental Example 3 Investigation on Hangover Relief
주정계를 이용하여 준비된 주류의 알코올 농도를 측정하였다. The alcohol concentration of the prepared liquor was measured using a spirit meter.
이후 유리병을 준비한 후 하기 주류들을 각각 100㎖를 넣고 동량의 실시예2의 건강보조식품을 넣은 후 균일하게 혼합될 정도로 흔들고, 12 시간 정도 경과 후 주정계를 이용하여 알코올 농도 변화를 측정하였다.Thereafter, after preparing the glass bottle, 100 ml of the following alcohols were added, and the same amount of the health supplement of Example 2 was shaken to be uniformly mixed, and after about 12 hours, the alcohol concentration was measured using a spirit meter.
(㎖)Alcohol consumption
(Ml)
(%)Alcohol concentration in alcohol
(%)
(㎖) Mixing amount of Example 2
(Ml)
상기 실험결과에서, 실시예 2의 건강보조식품2는 주류와 혼합하고 12시간 후 알코올 농도를 측정하여 그 알코올 농도가 저하됨을 확인하였다.In the experimental result, the health supplement 2 of Example 2 was mixed with the alcohol and after 12 hours to determine the alcohol concentration was confirmed that the alcohol concentration is lowered.
따라서, 본 발명의 땅빈대를 포함한 건강보조식품은 숙취해소에도 효과를 나타냄을 알 수 있었다.
Therefore, it was found that the health supplement foods including the landslides of the present invention have an effect on relieving hangovers.
<실험예 3> 관능검사 실시Experimental Example 3 Sensory Test
상기와 같이 구성된 본 발명의 건강보조식품1,2와 비교예 1의 건강보조식품에 대하여 향과 맛을 조사하여 전반적인 소비자들의 만족도를 조사하였다. The health and food supplements 1 and 2 of the present invention configured as described above and the health supplements of Comparative Example 1 were examined for the aroma and taste to investigate the overall consumer satisfaction.
연령과 성별을 고려하여 20 대 ~ 50 대 성인 남녀를 각각 연령대별로 5 명씩 총 20 명을 대상으로 조사하였으며, 향과 맛을 비교 조사하여 전반적인 소비자만족도를 조사하였다.In consideration of age and gender, a total of 20 males and females in their 20s to 50s were surveyed for each age group, and the overall consumer satisfaction was examined by comparing the flavors and tastes.
그 결과, 아래의 표 3에 나타내었다.As a result, it is shown in Table 3 below.
* 기호도 기준; 1. 아주 나쁘다., 3. 보통이다., 5. 아주 좋다.* Preference degree; 1. Very bad., 3. It is normal., 5. Very good.
상기 표 3과 같이 비교예 1의 건강보조식품은 땅빈대만을 열수추출한 것으로써 생약재 자체 쓴맛이 나 소비자들이 용이하게 이용하기에는 다소 어려운 점이 있어 전반적이 소비자만족도는 낮게 나타났는 반면, 본 발명인 실시예 1과 실시예 2의 건강보조식품은 여러가지 생약재가 잘 어울러져 쓴맛 및 신맛이 거의 나타나지 않으며 맛과 향이 좋아 소비자들이 용이하게 이용할 수 있어, 전반적으로 소비자들의 만족도가 높게 나타남을 확인하였다.As shown in Table 3, the health supplement food of Comparative Example 1 was extracted only by hot water, and the herbal medicine itself had a bitter taste or a somewhat difficult point to be easily used by consumers. And the health supplement of Example 2 is well matched with various herbal medicines almost no bitter and sour taste and good taste and aroma can be easily used by consumers, the overall customer satisfaction was confirmed to be high.
이에, 본 발명의 건강보조식품의 제조방법을 통해 기존의 생약재들을 이용한 건강보조식품의 문제점을 해소해 줌과 동시에 인체에 유익한 건강보조식품이 제조됨을 확인하였다.Thus, it was confirmed that through the method of manufacturing the health supplement food of the present invention solves the problems of the health supplement food using the existing herbal medicines and at the same time the health supplement foods beneficial to the human body is produced.
Claims (3)
상기 정선한 재료들을 용기에 넣고, 여기에 물을 넣고 100 ~ 120 ℃에서 1 ~ 4시간 동안 열수추출하는 단계;를 포함하여 구성된,
땅빈대를 포함한 건강보조식품의 제조방법.Preparing ingredients by selecting Euphorbia Humifusa wild , ginseng, Angelica, situation mushroom, licorice and jujube respectively; And
Put the selected materials in a container, water is added to it and extracting hot water for 1 to 4 hours at 100 ~ 120 ℃; comprising,
Method of manufacturing health supplements, including ground bedbugs.
상기 추출하는 단계에서, 땅빈대, 인삼, 당귀, 상황버섯, 감초, 대추를 1 : 0.02 ~ 0.1 : 0.02 ~ 0.1 : 0.01 ~ 0.05 : 0.02 ~ 0.1 : 0.05 ~ 0.2 중량비로 넣고추출하는 것을 특징으로 하는,
땅빈대를 포함한 건강보조식품의 제조방법.The method of claim 1,
In the step of extracting, extract the ground bug, ginseng, Angelica, situation mushroom, licorice, jujube 1: 0.02 ~ 0.1: 0.02 ~ 0.1: 0.01 ~ 0.05: 0.02 ~ 0.1: 0.05 ~ 0.2 by weight ,
Method of manufacturing health supplements, including ground bedbugs.
땅빈대를 포함한 건강보조식품.It consists of hot water extraction of mixed material mixed with ground bean, ginseng, donkey, situation mushroom, licorice, jujube in a ratio of 1: 0.02 ~ 0.1: 0.02 ~ 0.1: 0.01 ~ 0.05: 0.02 ~ 0.1: 0.05 ~ 0.2 with water,
Health supplements, including landslides.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100041200A KR100974584B1 (en) | 2010-05-03 | 2010-05-03 | Health assistance food included the euphorbia humifusa wild and the manufacturing method therof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100041200A KR100974584B1 (en) | 2010-05-03 | 2010-05-03 | Health assistance food included the euphorbia humifusa wild and the manufacturing method therof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100974584B1 true KR100974584B1 (en) | 2010-08-09 |
Family
ID=42759400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100041200A KR100974584B1 (en) | 2010-05-03 | 2010-05-03 | Health assistance food included the euphorbia humifusa wild and the manufacturing method therof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100974584B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017030419A1 (en) * | 2015-08-19 | 2017-02-23 | 원광대학교산학협력단 | Composition including euphorbia supina raf. extract or fraction as active ingredient for preventing or treating obesity |
-
2010
- 2010-05-03 KR KR1020100041200A patent/KR100974584B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017030419A1 (en) * | 2015-08-19 | 2017-02-23 | 원광대학교산학협력단 | Composition including euphorbia supina raf. extract or fraction as active ingredient for preventing or treating obesity |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100793204B1 (en) | Pharmaceutical Composition for Treating or Preventing Coronary Heart Diseases or Arteriosclerosis Containing an Extract of Chinese Herb as an Effective Ingredient | |
CN109007808A (en) | A kind of relieving alcoholism and protecting liver composition and the relieving alcoholism and protecting liver preparation comprising it | |
KR20110125295A (en) | Health assistance food used the euphorbia humifusa wild by main raw material and the manufacturing method therof | |
KR20200004942A (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
CN103181435B (en) | Lung moistening health tea and preparation method thereof | |
CN106359720A (en) | Health protection tea for clearing heat from throat and moistening lung and preparation method thereof | |
KR101060309B1 (en) | Restorative herb medicine with jujube and manufacturing method thereof | |
CN108578544A (en) | A kind of Chinese medicine composition and the preparation method and application thereof with blood sugar reducing function | |
KR100947278B1 (en) | A carbohydrate and lipid absorption inhibitory nelumbo composition and its manufacturing process thereof | |
KR100853829B1 (en) | A functional soy-bean source for preventing hypertension and improving lipid metabolism and process for preparation thereof | |
KR100793205B1 (en) | Health Supporting Foods for Improving Coronary Heart Diseases or Arteriosclerosis Containing an Extract of Chinese Herb as an Effective Ingredient | |
CN106720727A (en) | A kind of trollflower herbal tea and preparation method thereof | |
CN106106907A (en) | A kind of by the liver-protecting tea beverage prepared by leaf of Camellia nitidissima Chi | |
CN105941816A (en) | Chewing gum with healthcare functions and cyclocarya paliurus | |
EP1369123A1 (en) | A health-care product comprising lotus rhizome and process for its preparation | |
KR100974584B1 (en) | Health assistance food included the euphorbia humifusa wild and the manufacturing method therof | |
KR101160088B1 (en) | Herbal extracts composition for the prevention of alcoholic fatty liver, hyperlipidemia and hangover | |
CN102827740B (en) | Baisui (Chinese character) wine and preparation method thereof | |
KR101330687B1 (en) | Composition for treating and preventing obesity containing oriental herbal extracts | |
CN112057525A (en) | Miao medicine for regulating hypertension, hyperglycemia and hyperlipidemia and preparation process thereof | |
CN110301639A (en) | Drug extract, rhizoma polygonati compound oral liquid and preparation method with its preparation | |
KR100642801B1 (en) | Anti-diabetic food composition comprising extracts from natural herbal materials and pear and process for preparing the same | |
KR100545407B1 (en) | Food composition for the treatment of the hyperlipidemia and its process | |
CN108277135A (en) | A kind of eucommia health care wine and preparation method | |
KR102104772B1 (en) | Health functional food comprising crude drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |